Top Markets
Coin of the day
Spectral Medical Inc. Spectral Medical Inc.

Spectral Medical Inc.

EDT
Rang in aandelen #16672
Spectral Medical Inc. focuses on the development and commercialization of... Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Aandeelprijs
$0.95411796
Laatst gesynchroniseerd: 2026-09-01
Marktkapitalisatie
$279.96M
Verandering (1 dag)
-0.76%
Verandering (1 jaar)
-16.23%
Land
CA
Handel Spectral Medical Inc. (EDT)

Categorie

Winst voor Spectral Medical Inc. (EDT)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Spectral Medical Inc. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Spectral Medical Inc. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US